Review, approval, and marketing of biosimilars in the United States - Part 2: Ethical Issues

Serena Purdy, Amber W. Aagaard, Sean Philpott

Research output: Contribution to Newspaper/Magazine/Website › Article

Cite this

@misc{59a55a2e64134109979871e9e4d27652,

title = "Review, approval, and marketing of biosimilars in the United States - Part 2: Ethical Issues",

author = "Serena Purdy and Aagaard, {Amber W.} and Sean Philpott",

year = "2011",

month = jan,

language = "English",

volume = "9",

pages = "14--19",

journal = "BioProcess International",

issn = "1542-6319",

publisher = "PJB Publications Ltd.",

}

TY - GEN

T1 - Review, approval, and marketing of biosimilars in the United States - Part 2

T2 - Ethical Issues

AU - Purdy, Serena

AU - Aagaard, Amber W.

AU - Philpott, Sean

PY - 2011/1

Y1 - 2011/1

UR - http://www.scopus.com/inward/record.url?scp=78651384022&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:78651384022

SN - 1542-6319

VL - 9

SP - 14

EP - 19

JO - BioProcess International

JF - BioProcess International

ER -